Jump Into the Patient Pool: The Data's Lovely
How are Canadians using medical cannabis?
What?
The Canadian Medical Cannabis Experience: A 2019 Patient Retrospective Report aims to provide insights into how – and why – Canadians are using medical cannabis. The report profiles patients’ symptoms, which strains and types of cannabis they used, and their self-reported treatment outcomes.
How?
Using data gathered via outcome-tracking app Strainprint, from over 800,000 anonymous patient submissions between January and December 2018.
Why?
Currently, there are few guidelines available to doctors or patients advising them on best practices for the use of medical cannabis. By analyzing self-reported patient outcomes, the report hopes to shed light on what dosage, strain and delivery method patients found most effective for different conditions.
Who?
The report was published by Strainprint, a Canadian data-analytics company based in Ontario, Canada.
- Strainprint, “The Canadian medical cannabis experience: a 2019 patient perspective” (2019). Available at: https://bit.ly/2N7udMi. Accessed October 24, 2019.
Having thrown myself into various science communication activities whilst studying science at University, I soon came to realize where my passions truly lie; outside the laboratory, telling the stories of the remarkable men and women conducting groundbreaking research. Now, at Texere, I have the opportunity to do just that.
